Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo.

Virus-based nanoparticles (VNPs) from a variety of sources are being developed for biomedical and nanotechnology applications that include tissue targeting and drug delivery. However, the fate of most of those particles in vivo has not been investigated. Cowpea mosaic virus (CPMV), a plant comovirus, has been found to be amenable to the attachment of a variety of molecules to its coat protein, as well as to modification of the coat protein sequence by genetic means. We report here the results of studies of the bio-distribution, toxicology, and pathology of CPMV in mice. Plasma clearance and tissue biodistribution were measured using CPMV particles derivatized with lanthanide metal complexes. CPMV particles were cleared rapidly from plasma, falling to undetectable levels within 20 min. By 30 min the majority of the injected VNPs were trapped in the liver and to a lesser extent the spleen with undetectable amounts in other tissues. At doses of 1 mg, 10 mg and 100 mg per kg body weight, no toxicity was noted and the mice appeared to be normal. Hematology was essentially normal, although with the highest dose examined, the mice were somewhat leukopenic with relative decreases in both neutrophils and lymphocytes. Histological examination of the spleen showed cellular infiltration, which upon flow cytometry analyses revealed elevated B lymphocytes on the first day following virus administration that subsequently subsided. Microscopic evaluation of various other tissues revealed a lack of apparent tissue degeneration or necrosis. Overall, CPMV appears to be a safe and non-toxic platform for in vivo biomedical applications.

Viral MRI contrast agents: coordination of Gd by native virions and attachment of Gd complexes by azide-alkyne cycloaddition.

Icosahedral virus particles decorated with a Gd(DOTA) analogue by Cu-mediated azide-alkyne cycloaddition (CuAAC) and/or with Gd(3+) ions by coordination to the viral nucleoprotein show increased T(1) relaxivity relative to free Gd(DOTA) complexes in solution.

Supramolecular asymmetric induction in dinuclear triple-stranded helicates.

Supramolecular chiral induction has been observed in five dinuclear triple-stranded helicates composed entirely of achiral components. Three different chiral cations were found to be very effective at inducing high levels of enantiomeric enrichment in racemic mixtures of the helicates. The mechanism of intermolecular chiral induction in one cation-helicate pair, s-nic/K6[Ga2L(1)3], has been elucidated through circular dichroism spectroscopy, X-ray crystallography, and one and two-dimensional NMR spectroscopy (s-nic = N-methyl-s-nicotinium, H4L(1) = 1,4-bis(2',3'-dihydroxybenzamido)phenylene).

Large M4L4 (M = Al(III), Ga(III), In(III), Ti(IV)) tetrahedral coordination cages: an extension of symmetry-based design.

As an extension to a rational design for the formation of self-assembled coordination cages, the syntheses for very large M4L4 tetrahedra based on a hexadentate 3-fold symmetric ligand (1,3,5-tris(4'-(2' ',3' '-dihydroxybenzamido)phenyl)benzene (H6L2)) are described. Four tetrahedral M4L2(4) assemblies (M = Al(III), Ga(III), In(III), Ti(IV)), with cavity sizes of around 450 A3, have been characterized by elemental analysis, NMR spectroscopy, and high-resolution electrospray mass spectrometry. Differences in chiral resolution and dynamic behavior of host-guest interactions with previously reported tetrahedral M4L(N)6 and M4L1(4) architectures are highlighted for the ligands 1,5-bis(2',3'-dihydroxybenzamido)naphthalene (H4L(N)) and 1,3,5-tris(2',3'-dihydroxybenzamido)benzene (H6L1). An even larger 3-fold symmetric ligand, 1,3,5-tris(4'-(2' '',3' ''-dihydroxybenzamido)-1',1' '-biphenyl)benzene (H6L3) has been prepared but, due to increased flexibility and deviation from the intended 3-fold symmetry, does not undergo self-assembly to form the M4L3(4) structure.